Medline (NASDAQ: MDLN) recently received a number of ratings updates from brokerages and research firms:
- 10/22/2026 – Medline had its price target lowered by Mizuho from $48.00 to $45.00. They now have an “outperform” rating on the stock.
- 10/20/2026 – Medline was downgraded by Zacks Research from “hold” to “strong sell”.
- 10/9/2026 – Medline had its price target lowered by Barclays from $45.00 to $43.00. They now have an “overweight” rating on the stock.
- 10/8/2026 – Medline was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
- 9/25/2026 – Medline had its price target lowered by UBS Group from $45.00 to $43.00. They now have a “buy” rating on the stock.
- 9/23/2026 – Medline had its “outperform” rating reaffirmed by William Blair.
- 8/27/2026 – Medline had its “buy” rating reaffirmed by BTIG Research. They now have a $55.00 price target on the stock.
Insider Transactions at Medline
In other Medline news, major shareholder Private Ltd Gic sold 2,570,999 shares of Medline stock in a transaction that occurred on Friday, October 2nd. The shares were sold at an average price of $35.35, for a total value of $90,884,814.65. Following the transaction, the insider owned 20,231,483 shares in the company, valued at approximately $715,182,924.05. The trade was a 11.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 10,787,572 shares of company stock valued at $382,784,591 in the last quarter. Insiders own 0.81% of the company’s stock.
Medline Industries, Inc is a medical-supply manufacturer and distributor headquartered in Northfield, Illinois. The company provides products and supply-chain services to healthcare organizations, including hospitals, ambulatory surgery centers, physician offices, long-term care facilities, home health providers and other care settings.
Its product portfolio includes medical-surgical supplies, surgical and operating-room products, patient-care items, examination gloves, protective apparel, laboratory products, respiratory-care equipment, durable medical equipment and products for infection prevention.
Featured Articles
- Five stocks we like better than Medline
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for Medline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medline and related companies with MarketBeat.com's FREE daily email newsletter.
